How to measure cholecystokinin in plasma?
Rehfeld, J.F.
Gastroenterology 87(2): 434-438
1984
ISSN/ISBN: 0016-5085 PMID: 6735087 Document Number: 235514
Document emailed within 1 workday
Related Documents
Lilja, P.; Fagan, C.J.; Wiener, I.; Inoue, K.; Watson, L.C.; Rayford, P.L.; Thompson, J.C. 1982: Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size Gastroenterology 83(1 Pt 2): 256-261Brenner, L.; Yox, D.P.; Ritter, R.C. 1993: Suppression of sham feeding by intraintestinal nutrients is not correlated with plasma cholecystokinin elevation American Journal of Physiology 264(5 Pt 2): R972-R976
Masclee, A.A.; Jansen, J.B.; Driessen, W.M.; Geuskens, L.M.; Lamers, C.B. 1989: Delayed plasma cholecystokinin and gallbladder responses to intestinal fat in patients with Billroth i and Ii gastrectomy Surgery 106(3): 502-508
Rodriguez, M.; Lignon, M.F.; Galas, M.C.; Amblard, M.; Martinez, J. 1990: Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors Molecular Pharmacology 38(3): 333-341
Burhol, P.G.; Jenssen, T.G.; Jorde, R.; Lygren, I.; Johnson, J.A. 1984: Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation International Journal of Obesity 8(3): 233-236
Kanayama, S.; Himeno, S.; Kurokawa, M.; Shinomura, Y.; Kuroshima, T.; Okuno, M.; Tsuji, K.; Higashimoto, Y.; Ikei, N.; Hashimura, E. 1985: Marked prolongation in disappearance half-time of plasma cholecystokinin-octapeptide in patients with hepatic cirrhosis American Journal of Gastroenterology 80(7): 557-560
Busch, A.; Prager, S.; Heil, K. 1996: The measurement of long logs: a comparison of harvester measure, manual measure and works measure Forst und Holz 51(23): 778-779
Jansen, J.B.; Lamers, C.B. 1984: Effect of bombesin on plasma cholecystokinin in normal persons and gastrectomized patients measured by sequence-specific radioimmunoassays Surgery 96(1): 55-60
Mössner, J.; Sprenger, C.; Secknus, R.; Kestel, W.; Fischbach, W. 1991: Comparison between the synthetic cholecystokinin analogues caerulein and Thr28NlE31CCK25-33(CCK9) with regards to plasma bioactivity, degradation rate and stimulation of pancreatic exocrine function Zeitschrift für Gastroenterologie 29(2): 59-64
Himeno, S.; Tarui, S.; Kanayama, S.; Kuroshima, T.; Shinomura, Y.; Hayashi, C.; Tateishi, K.; Imagawa, K.; Hashimura, E.; Hamaoka, T. 1983: Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay American Journal of Gastroenterology 78(11): 703-707
Riepl, R.L.; Fiedler, F.; Kowalski, C.; Teufel, J.; Lehnert, P. 1996: Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man Italian Journal of Gastroenterology 28(8): 421-429
Olson, P.N.; Bowen, R.A.; Behrendt, M.D.; Olson, J.D.; Nett, T.M. 1984: Validation of radioimmunoassays to measure prostaglandins F2 alpha and E2 in canine endometrium and plasma American Journal of Veterinary Research 45(1): 119-124
Pussard, E.; Guigueno, N.; Adam, O.; Giudicelli, J.F. 1996: Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine Clinical Chemistry 42(7): 1086-1091
Belova, L.A.; Ogloblina, O.G.; Tvorogova, M.G. 1996: A method to eliminate lipids from blood plasma in hyperlipidemias to measure activities of proteinases and their inhibitors Klinicheskaia Laboratornaia Diagnostika 3: 50-51
Hussey, A.J.; Aldridge, L.M.; Paul, D.; Ray, D.C.; Beckett, G.J.; Allan, L.G. 1988: Plasma glutathione S-transferase concentration as a measure of hepatocellular integrity following a single general anaesthetic with halothane, enflurane or isoflurane British Journal of Anaesthesia 60(2): 130-135
Mbida, A.é D.é; Sosso, S.; Flori, P.; Saoudin, H.; Lawrence, P.; Monny-Lobé, M.; Oyono, Y.; Ndzi, E.; Cappelli, G.; Lucht, F.éd.ér.; Pozzetto, B.; Oukem-Boyer, O.O.M.; Bourlet, T. 2009: Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon Journal of Acquired Immune Deficiency Syndromes 52(1): 9-16
Waldman, J.Deane. 2006: Change your metrics: if you get what you measure, then measure what you want--retention Journal of Medical Practice Management: Mpm 22(1): 13-19
Mekuria, L.A.; Prins, J.M.; Yalew, A.W.; Sprangers, M.A.G.; Nieuwkerk, P.T. 2016: Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring? Tropical Medicine and International Health: Tm and Ih 21(7): 856-869
Kleinman, L.; Benjamin, K.; Viswanathan, H.; Mattera, M.Stoeckl.; Bosserman, L.; Blayney, D.W.; Revicki, D.A. 2012: The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation 21(7): 1255-1266
Reinberg, A.; Dupont, W.; Touitou, Y.; Lagoguey, M.; Bourgeois, P.; Touitou, C.; Muriaux, G.; Przyrowsky, D.; Guillemant, S.; Guillemant, J.; Brière, L.; Zeau, B. 1981: Clinical chronopharmacology of ACTH 1-17. II. Effects on plasma testosterone, plasma aldosterone, plasma and urinary electrolytes (K, Na, Ca and Mg) Chronobiologia 8(1): 11-31